Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Eliot Mostow MD, MPH
Eliot N. Mostow MD, MPH Associate Editor
Christen Mowad MD
Christen Maria Mowad MD Advisory Board
Ashish Bhatia MD, FAAD
Ashish C. Bhatia MD, FAAD Associate Editor
See All Experts
featured
Published in Dermatology

Journal Scan / Research · January 06, 2014

Antibody Formation Against Adalimumab Strongly Influences Response

JAMA Dermatology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Robert Brodell MD, FAAD

JAMA Dermatology
Extent and Consequences of Antibody Formation Against Adalimumab in Patients With Psoriasis: One-Year Follow-up
JAMA Dermatol 2013 Dec 18;[EPub Ahead of Print], SP Menting, PP van Lümig, AC de Vries, JM van den Reek, D van der Kleij, EM de Jong, PI Spuls, LL Lecluse

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated